|
TMEM14A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.40090000000515E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.06670000055153E-07 |
| Normal-vs-Stage2 |
1.398430E-02 |
| Normal-vs-Stage3 |
3.144000E-01 |
| Normal-vs-Stage4 |
3.233800E-02 |
| Stage1-vs-Stage2 |
6.335200E-01 |
| Stage1-vs-Stage3 |
7.865700E-02 |
| Stage1-vs-Stage4 |
3.450200E-01 |
| Stage2-vs-Stage3 |
2.957800E-01 |
| Stage2-vs-Stage4 |
6.345800E-01 |
| Stage3-vs-Stage4 |
5.416000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.70399999996651E-06 |
| Normal-vs-AfricanAmerican |
2.939000E-01 |
| Normal-vs-Asian |
7.753600E-01 |
| Caucasian-vs-AfricanAmerican |
4.516400E-01 |
| Caucasian-vs-Asian |
5.634200E-02 |
| AfricanAmerican-vs-Asian |
5.966600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84809000000064E-05 |
| Normal-vs-Female |
1.458240E-01 |
| Male-vs-Female |
1.044460E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.336900E-03 |
| Normal-vs-Extreme_Weight |
3.06859999632536E-08 |
| Normal-vs-Obese |
2.122400E-03 |
| Normal-vs-Extreme_Obese |
6.980300E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.488990E-01 |
| Normal_Weight-vs-Obese |
6.835400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.176200E-01 |
| Extreme_Weight-vs-Obese |
3.899500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.674800E-01 |
| Obese-vs-Extreme_Obese |
7.323200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.186600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.723900E-02 |
| Normal-vs-Age(61-80Yrs) |
3.05259999999752E-06 |
| Normal-vs-Age(81-100Yrs) |
4.11340000000537E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.402400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.137700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.705500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.958600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.343800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.567600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.006300E-04 |
| Normal-VS-Type2 PRCC |
2.550200E-02 |
| Normal-VS-KIRP CIMP |
7.916600E-01 |
| Normal-VS-Unclassified PRCC |
4.03800000003951E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.279600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.492400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.859400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.417600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.464400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.028300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.418060E-04 |
| Normal-vs-N1 |
2.526000E-01 |
| Normal-vs-N2 |
5.637800E-04 |
| N0-vs-N1 |
5.024000E-02 |
| N0-vs-N2 |
4.162400E-01 |
| N1-vs-N2 |
1.720340E-02 |
|
|
